Effect of mycophenolic acid on cyclosporin A-induced fibronectin expression in rat mesangial cells

Pharmacology. 2013;91(1-2):20-8. doi: 10.1159/000343764. Epub 2012 Nov 7.

Abstract

This study was undertaken to determine if mycophenolic acid (MPA) inhibits the profibrotic action of cyclosporin A (CsA) and, if so, to determine the molecular mechanisms involved. The effect of MPA treatment on CsA-induced signaling through the transforming growth factor-β (TGF-β)/Smad pathway was evaluated by immunoblot analysis in cultured primary rat mesangial cells. Treatment of cells with 1 µmol/l MPA did not significantly decrease the CsA-induced expression of TGF-β(1), but partially reversed the increases in Smad3 phosphorylation and fibronectin (FBN) production, and increased Smad7 expression. These results suggest that MPA may ameliorate CsA-induced FBN production by modulating the Smad signaling pathway. This study provides evidence that MPA can attenuate CsA-induced renal injury after kidney transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cyclosporine / administration & dosage*
  • Fibronectins / metabolism*
  • Gene Knockdown Techniques
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Mesangial Cells / drug effects*
  • Mesangial Cells / metabolism
  • Mycophenolic Acid / administration & dosage*
  • RNA, Small Interfering / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Smad3 Protein / genetics
  • Smad3 Protein / metabolism
  • Smad7 Protein / genetics
  • Smad7 Protein / metabolism
  • Transforming Growth Factor beta / metabolism

Substances

  • Fibronectins
  • Immunosuppressive Agents
  • RNA, Small Interfering
  • Smad3 Protein
  • Smad3 protein, rat
  • Smad7 Protein
  • Smad7 protein, rat
  • Transforming Growth Factor beta
  • Cyclosporine
  • Mycophenolic Acid